Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Lipocine (LPCN) over the last 13 years, with Q3 2025 value amounting to $143027.0.

  • Lipocine's Non-Current Assets fell 2641.89% to $143027.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $662263.0, marking a year-over-year increase of 1255.55%. This contributed to the annual value of $188828.0 for FY2024, which is 3502.37% up from last year.
  • According to the latest figures from Q3 2025, Lipocine's Non-Current Assets is $143027.0, which was down 2641.89% from $157150.0 recorded in Q2 2025.
  • In the past 5 years, Lipocine's Non-Current Assets ranged from a high of $6.1 million in Q4 2021 and a low of $23753.0 during Q2 2021
  • Moreover, its 5-year median value for Non-Current Assets was $188828.0 (2024), whereas its average is $1.8 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 2559260.3% in 2021, then plummeted by 9638.64% in 2024.
  • Quarter analysis of 5 years shows Lipocine's Non-Current Assets stood at $6.1 million in 2021, then plummeted by 44.16% to $3.4 million in 2022, then plummeted by 95.9% to $139848.0 in 2023, then surged by 35.02% to $188828.0 in 2024, then fell by 24.26% to $143027.0 in 2025.
  • Its last three reported values are $143027.0 in Q3 2025, $157150.0 for Q2 2025, and $173258.0 during Q1 2025.